Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.
Immune checkpoint blockade with therapeutic anti-cytotoxic T lymphocyte-associated antigen (CTLA)-4 (Ipilimumab) and anti-programmed death (PD)-1 (Nivolumab and Pembrolizumab) antibodies alone or in combination has shown remarkable efficacy in multiple cancer types, concomitant with immune-related a...
Main Authors: | Yanxia Guo, Alice M Walsh, Mary Canavan, Mihir D Wechalekar, Suzanne Cole, Xuefeng Yin, Brittney Scott, Mathew Loza, Carl Orr, Trudy McGarry, Michele Bombardieri, Frances Humby, Susanna M Proudman, Costantino Pitzalis, Malcolm D Smith, Joshua R Friedman, Ian Anderson, Loui Madakamutil, Douglas J Veale, Ursula Fearon, Sunil Nagpal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5831027?pdf=render |
Similar Items
-
ACPA Status Correlates with Differential Immune Profile in Patients with Rheumatoid Arthritis
by: Achilleas Floudas, et al.
Published: (2021-03-01) -
Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium
by: Susanna M Proudman, et al.
Published: (2022-10-01) -
Editorial: Synovial pathobiology and pathogenesis of inflammatory arthritis
by: Annabelle Small, et al.
Published: (2022-08-01) -
Regulatory role of CCL21 in the recruitment and exit of immune cells in rheumatoid synovium
by: Manzo, A, et al.
Published: (2005) -
CCL21 relationship with lymphoid neogenesis and lymphatic vascular system in chronically inflamed synovium
by: Manzo, A, et al.
Published: (2005)